NATCO Pharma updates on legal proceedings on Risdiplam launch in India
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
The stethoscope features high acoustic sensitivity and active noise cancellation, minimizing ambient interference to improve auscultation clarity, particularly in noisy hospital settings
The introduction of Coveris’ sleeve-to-sleeve PCR model complements sectors such as bottling where an established recycling infrastructure exists
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
AstraZeneca Pharma India discontinues manufacturing of Imdur
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Subscribe To Our Newsletter & Stay Updated